Table 2.
Parameter | HC (n = 20) | Study Group (n = 120) | p-Value | Post hoc p-value | |
---|---|---|---|---|---|
No TBI-AC (n = 70) | TBI-AC (n = 50) | ||||
Thrombomodulin (ng/mL) | 11.0(8.6–12.6) | 11.8(4.9–86.2) | 10.2(3.9–84.0) | 0.76 | - |
Syndecan-1 (ng/mL) | 24.8(21.5–30.6) | 29.9(19.2–39.5) | 33.7(21.6–109.5) | 0.03 | HC vs. No TBI-AC 0.20 HC vs. TBI-AC 0.04 No TBI-AC vs. TBI-AC 0.03 |
Continuous variables were reported as median (interquartile range), and compared using Wilcoxon rank-sum test. Bold depicts significant p-value.